# Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies

Study · id `cardio:ct-nct04524247` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04524247](<https://clinicaltrials.gov/study/NCT04524247>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04524247

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT04524247. Allocation not applicable; no masking; primary purpose treatment. Start 2021-02-23 (actual); primary completion 2028-07-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT04524247, source copy `cardio:ctgov-nct04524247-2024-07-01`, retrieved 2026-11-18)
- Started: 2021-02-23 (actual) (ClinicalTrials.gov record NCT04524247, source copy `cardio:ctgov-nct04524247-2024-07-01`, retrieved 2026-11-18)
- Primary completion: 2028-07-02 (anticipated) (ClinicalTrials.gov record NCT04524247, source copy `cardio:ctgov-nct04524247-2024-07-01`, retrieved 2026-11-18)
- Completion: 2032-07-02 (anticipated) (ClinicalTrials.gov record NCT04524247, source copy `cardio:ctgov-nct04524247-2024-07-01`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT04524247, source copy `cardio:ctgov-nct04524247-2024-07-01`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04524247-2024-07-01`, retrieved 2026-11-18)

## The registry's words

- Brief title: Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies
- Condition: Thoracoabdominal Aortic Aneurysm
- Condition: Thoracoabdominal; Aortic, Aneurysm, Dissecting
- Condition: Pararenal Aneurysm
- Condition: Frailty Syndrome
- Intervention (Device): Physician Modified Endografts
- Lead sponsor: University of Southern California
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: University of Southern California (`cardio:org-university-of-southern-california`)

## Provenance

Content hash: d1b2273f4336d94e815654f4bcdf6e9f9c0f1aeb139512566f41487f91486c52
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
